Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II

Virology

Volumn 363, Issue 1, 2007, Pages 113-123

  Homann, Dirk ^a   Lewicki, Hanna ^b   Brooks, David ^b   Eberlein, Jens ^a   Mallet Designé, Valerie ^b   Teyton, Luc ^b   Oldstone, Michael B A ^b  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

CD4; CD8; LCMV; MHC class I; MHC class II; T cell response; Virus

Indexed keywords

AMINO ACID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CLONE; CONTROLLED STUDY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESTRICTION MAPPING; SURFACE PLASMON RESONANCE;

AMINO ACID SEQUENCE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNODOMINANT EPITOPES; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, CYTOTOXIC;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

EID: 34247628903     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.12.025     Document Type: Article

References (55)

1. Anderson J., Byrne J.A., Schreiber R., Patterson S., and Oldstone M.B. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus and in vitro properties. J. Virol. 53 2 (1985) 552-560
2. Apostolopoulos V., Yu M., Corper A.L., Li W., McKenzie I.F., Teyton L., Wilson I.A., and Plebanski M. Crystal structure of a non-canonical high affinity peptide complexed with MHC class I: a novel use of alternative anchors. J. Mol. Biol. 318 5 (2002) 1307-1316
3. Appay V. The physiological role of cytotoxic CD4 (+) T-cells: the holy grail?. Clin. Exp. Immunol. 138 1 (2004) 10-13
4. Belkaid Y., and Rouse B.T. Natural regulatory T cells in infectious disease. Nat. Immunol. 6 4 (2005) 353-360
5. Berger D.P., Homann D., and Oldstone M.B. Defining parameters for successful immunocytotherapy of persistent viral infection. Virology 266 2 (2000) 257-263
6. Bevan M.J. Helping the CD8 (+) T-cell response. Nat. Rev., Immunol. 4 8 (2004) 595-602
7. Burton D.R. Opinion: antibodies, viruses and vaccines. Nat. Rev., Immunol. 2 9 (2002) 706-713
8. Corper A.L., Stratmann T., Apostolopoulos V., Scott C.A., Garcia K.C., Kang A.S., Wilson I.A., and Teyton L. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 288 5465 (2000) 505-511
9. Dittmer U., He H., Messer R.J., Schimmer S., Olbrich A.R., Ohlen C., Greenberg P.D., Stromnes I.M., Iwashiro M., Sakaguchi S., Evans L.H., Peterson K.E., Yang G., and Hasenkrug K.J. Functional impairment of CD8 (+) T cells by regulatory T cells during persistent retroviral infection. Immunity 20 3 (2004) 293-303
10. Dongre A.R., Kovats S., deRoos P., McCormack A.L., Nakagawa T., Paharkova-Vatchkova V., Eng J., Caldwell H., Yates J.R., and Rudensky A.Y. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses. Eur. J. Immunol. 31 5 (2001) 1485-1494
11. Falk K., Rotzschke O., Stevanovic S., Jung G., and Rammensee H.G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351 6324 (1991) 290-296
12. Fremont D.H., Matsumura M., Stura E.A., Peterson P.A., and Wilson I.A. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science 257 5072 (1992) 919-927
13. Gairin J.E., Mazarguil H., Hudrisier D., and Oldstone M.B. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes. J. Virol. 69 4 (1995) 2297-2305
14. Garcia K.C., Tallquist M.D., Pease L.R., Brunmark A., Scott C.A., Degano M., Stura E.A., Peterson P.A., Wilson I.A., and Teyton L. Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. Proc. Natl. Acad. Sci. U. S. A. 94 25 (1997) 13838-13843
15. Homann D. Immunocytotherapy. Curr. Top. Microbiol. Immunol. 263 (2002) 43-65
16. Homann D., Tishon A., Berger D.P., Weigle W.O., von Herrath M.G., and Oldstone M.B. Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice. J. Virol. 72 11 (1998) 9208-9216
17. Homann D., Teyton L., and Oldstone M.B. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat. Med. 7 8 (2001) 913-919
18. Homann D., Jahreis A., Wolfe T., Hughes A., Coon B., van Stipdonk M.J., Prilliman K.R., Schoenberger S.P., and von Herrath M.G. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 16 3 (2002) 403-415
19. Homann D., Dummer W., Wolfe T., Rodrigo E., Theofilopoulos A.N., Oldstone M.B., and von Herrath M.G. Lack of intrinsic ctla-4 expression has minimal effect on regulation of antiviral T-cell immunity. J. Virol. 80 1 (2006) 270-280
20. Hudrisier D., Oldstone M.B., and Gairin J.E. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D (b) and H-2K (b) molecules. Virology 234 1 (1997) 62-73
21. Jenkins M.K., Khoruts A., Ingulli E., Mueller D.L., McSorley S.J., Reinhardt R.L., Itano A., and Pape K.A. In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol. 19 (2001) 23-45
22. Kamperschroer C., and Quinn D.G. Quantification of epitope-specific MHC class-II-restricted T cells following lymphocytic choriomeningitis virus infection. Cell. Immunol. 193 2 (1999) 134-146
23. Klavinskis L.S., Whitton J.L., Joly E., and Oldstone M.B. Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology 178 2 (1990) 393-400
24. Krummel M., Wulfing C., Sumen C., and Davis M.M. Thirty-six views of T-cell recognition. Philos. Trans. R. Soc. London, Ser. B Biol. Sci. 355 1400 (2000) 1071-1076
25. Lenz D.C., Kurz S.K., Lemmens E., Schoenberger S.P., Sprent J., Oldstone M.B., and Homann D. IL-7 regulates basal homeostatic proliferation of antiviral CD4+T cell memory. Proc. Natl. Acad. Sci. U. S. A. 101 25 (2004) 9357-9362
26. + T cells using recombinant artificial APC: following the anti-ovalbumin immune response. J. Immunol. 170 1 (2003) 123-131
27. Matsumura M., Saito Y., Jackson M.R., Song E.S., and Peterson P.A. In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells. J. Biol. Chem. 267 33 (1992) 23589-23595
28. McHeyzer-Williams M., McHeyzer-Williams L., Panus J., Pogue-Caley R., Bikah G., Driver D., and Eisenbraun M. Helper T-cell-regulated B-cell immunity. Microbes Infect. 5 3 (2003) 205-212
29. Meiring H.D., Kuipers B., van Gaans-van den Brink J.A., Poelen M.C., Timmermans H., Baart G., Brugghe H., van Schie J., Boog C.J., de Jong A.P., and van Els C.A. Mass tag-assisted identification of naturally processed HLA class II-presented meningococcal peptides recognized by CD4+ T lymphocytes. J. Immunol. 174 9 (2005) 5636-5643
30. Mittrucker H.W., and Kaufmann S.H. Mini-review: regulatory T cells and infection: suppression revisited. Eur. J. Immunol. 34 2 (2004) 306-312
31. Norris P.J., and Rosenberg E.S. CD4 (+) T helper cells and the role they play in viral control. J. Mol. Med. 80 7 (2002) 397-405
32. Oldstone M.B., Whitton J.L., Lewicki H., and Tishon A. Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes. J. Exp. Med. 168 2 (1988) 559-570
33. Ostrov D.A., Roden M.M., Shi W., Palmieri E., Christianson G.J., Mendoza L., Villaflor G., Tilley D., Shastri N., Grey H., Almo S.C., Roopenian D., and Nathenson S.G. How H13 histocompatibility peptides differing by a single methyl group and lacking conventional MHC binding anchor motifs determine self-nonself discrimination. J. Immunol. 168 1 (2002) 283-289
34. Ovsyannikova I.G., Johnson K.L., Naylor S., Muddiman D.C., and Poland G.A. Naturally processed measles virus peptide eluted from class II HLA-DRB1*03 recognized by T lymphocytes from human blood. Virology 312 2 (2003) 495-506
35. Oxenius A., Bachmann M.F., Ashton-Rickardt P.G., Tonegawa S., Zinkernagel R.M., and Hengartner H. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system. Eur. J. Immunol. 25 12 (1995) 3402-3411
36. Pearce E.L., Shedlock D.J., and Shen H. Functional characterization of MHC class II-restricted CD8+CD4- and CD8-CD4- T cell responses to infection in CD4-/- mice. J. Immunol. 173 4 (2004) 2494-2499
37. Schulz M., Aichele P., Vollenweider M., Bobe F.W., Cardinaux F., Hengartner H., and Zinkernagel R.M. Major histocompatibility complex-dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease. Eur. J. Immunol. 19 9 (1989) 1657-1667
38. Scott C.A., Garcia K.C., Carbone F.R., Wilson I.A., and Teyton L. Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules. J. Exp. Med. 183 5 (1996) 2087-2095
39. Scott C.A., Peterson P.A., Teyton L., and Wilson I.A. Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity 8 3 (1998) 319-329
40. Seder R.A., and Ahmed R. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat. Immunol. 4 9 (2003) 835-842
41. Seder R.A., and Paul W.E. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12 (1994) 635-673
42. Sprent J., and Surh C.D. T cell memory. Annu. Rev. Immunol. 20 (2002) 551-579
43. Suri A., Lovitch S.B., and Unanue E.R. The wide diversity and complexity of peptides bound to class II MHC molecules. Curr. Opin. Immunol. 18 1 (2006) 70-77
44. Tyznik A.J., Sun J.C., and Bevan M.J. The CD8 population in CD4-deficient mice is heavily contaminated with MHC class II-restricted T cells. J. Exp. Med. 199 4 (2004) 559-565
45. van der Most R.G., Murali-Krishna K., Whitton J.L., Oseroff C., Alexander J., Southwood S., Sidney J., Chesnut R.W., Sette A., and Ahmed R. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. Virology 240 1 (1998) 158-167
46. van der Most R.G., Murali-Krishna K., Lanier J.G., Wherry E.J., Puglielli M.T., Blattman J.N., Sette A., and Ahmed R. Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation. Virology 315 1 (2003) 93-102
47. Varga S.M., and Welsh R.M. Detection of a high frequency of virus-specific CD4+ T cells during acute infection with lymphocytic choriomeningitis virus. J. Immunol. 161 7 (1998) 3215-3218
48. Varga S.M., and Welsh R.M. Stability of virus-specific CD4+ T cell frequencies from acute infection into long term memory. J. Immunol. 161 1 (1998) 367-374
49. Varga S.M., and Welsh R.M. High frequency of virus-specific interleukin-2-producing CD4 (+) T cells and Th1 dominance during lymphocytic choriomeningitis virus infection. J. Virol. 74 9 (2000) 4429-4432
50. Whitmire J.K., Asano M.S., Murali-Krishna K., Suresh M., and Ahmed R. Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection. J. Virol. 72 10 (1998) 8281-8288
51. Whitmire J.K., Benning N., and Whitton J.L. Precursor frequency, nonlinear proliferation, and functional maturation of virus-specific CD4+ T cells. J. Immunol. 176 5 (2006) 3028-3036
52. Whitton J.L., and Oldstone M.B. The immune response to viruses. In: Knipe D., Howley P., Griffin D., Lamb R., Martin M., and Strauss S. (Eds). Field's Virology. 4 ed (2001), Lippincott Williams and Wilkins, Philadelphia 285-320
53. Wolint P., Betts M.R., Koup R.A., and Oxenius A. Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells. J. Exp. Med. 199 7 (2004) 925-936
54. Zhu Y., Rudensky A.Y., Corper A.L., Teyton L., and Wilson I.A. Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif. J. Mol. Biol. 326 4 (2003) 1157-1174
55. Zinkernagel R.M. On differences between immunity and immunological memory. Curr. Opin. Immunol. 14 4 (2002) 523-536